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The Role of MRGPRX2/Mrgprb2 in Regulating Mast Cell Function
Abstract
Mast"cells"(MCs)"are"derived"from"bone"marrow"pluripotent"hematopoietic" stem" cells" and" are" located"
in" close" proximity" to" the" external" environment." MCs"
expresses"several"receptors"on"their"surface"such"as"the"high"affinity"IgE"receptor"
(Fc!RI)"and"G"ProteinECoupled"Receptors"(GPCRs)."MRGPRX2"is"a"GPCR,"which"
consists"of "seven"transmembrane"domains"and"is"expressed"exclusively"in"MCs" but" no" other" immune"
cells." This" receptor" is" activated" by" multiple" amphipathic" ligands" including" neuropeptides," US" Food"
and" Drug" Administration" (FDA)E
approved"peptidergic"drugs"and"host"defense"peptides"such"as"LL_37."HDPs"also" known" as"
antimicrobial" peptides" (AMPs)" have" been" investigated" in" depth" as" an"
alternative"to"overcome"antibiotic"resistance"crisis."However,"their"susceptibility"to"
degradation,"cytotoxicity"and"high"production"expenses"have"limited"their"use."To" overcome" these"
limitations," nonEpeptide" small" molecule" HDP" mimetics" (smHDPMs)" that" structurally" resemble" the"
AMPs" properties" but" have" better"
stability"and"less"cytotoxicity"have"been"developed."We"utilized"five"smHDPMs"and" found" that" these"




MCs" can" also" participate" in" chronic" inflammatory" diseases" when" innate" immunity" is" dysregulated."





MRGPRX2"in#vitro.#Utilizing"Mrgprb2"knockout"mice"(Mrgprb2E/E)"we"demonstrated" a" reduction" in"
erythema" presentation," inflammatory" cell" recruitment," MMP+9" and"
CXCL+2"mRNA"expression"compared"to"WT"mice"following"intradermal"injection" of " LLE37" and" SP"
to" rosacea" model." Calcium" signaling" is" essential" for" MC" degranulation" and" function." In" this"
dissertation" we" present" an" evidence" that" STIM1/Orai1" plays" an" important" role" in" MRGPRX2"
mediated" calcium" influx" and" mediators"release"when"stimulated"with"LLE37"and"SP.""
Moreover,"this"dissertation"showed"naturally"occurring"missense"mutations" of " MRGPRX2" both" within"
and" outside" the" receptor’s" predicted" ligand" binding" pocket" (G165E," D184H," W243R" and" H259Y)"
renders" it" unresponsive" neuropeptides," HDPs" and" peptidergic" drugs" for" MC" degranulation." Thus,"
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but" no" other" immune" cells." This" receptor" is" activated" by" multiple" amphipathic"





overcome" these" limitations," nonEpeptide" small" molecule" HDP" mimetics"
(smHDPMs)" that" structurally" resemble" the" AMPs" properties" but" have" better"
stability"and"less"cytotoxicity"have"been"developed."We"utilized"five"smHDPMs"and"




MCs" can" also" participate" in" chronic" inflammatory" diseases" when" innate"








of" LLE37" and" SP" to" rosacea" model." Calcium" signaling" is" essential" for" MC"
degranulation" and" function." In" this" dissertation" we" present" an" evidence" that"
STIM1/Orai1"plays"an" important" role" in"MRGPRX2"mediated"calcium" influx"and"
mediators"release"when"stimulated"with"LLE37"and"SP.""
Moreover,"this"dissertation"showed"naturally"occurring"missense"mutations"
of" MRGPRX2" both" within" and" outside" the" receptor’s" predicted" ligand" binding"
pocket" (G165E," D184H," W243R" and" H259Y)" renders" it" unresponsive"
neuropeptides," HDPs" and" peptidergic" drugs" for" MC" degranulation." Thus,"





































































































































































Chapter 1: Introduction 
 






a" mature" form" [2]." MCs" reside" in" all" vascularized" tissue" in" close" proximity" to"
external"stimuli"such"as"skin"and"respiratory"tract."They"are" longElived"cells" that"







for"many"researchers."Their"strategic" location"allows"MCs" to"be"one"of" the" first"
responders" in" innate"defense"to"any"pathogens,"allergen"or"toxin"encounter" [4]."
This" location" also" enables" the"MCs" to" interact"with" blood" vessels" by" releasing"
factors"such"as"ILE8,""TNFE","histamine,"and"vascular"endothelial"growth"factors"
(VEGFs)"which" contribute" to" the" local" vascular" permeability" and" recruitment" of"
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other"immune"cells"at"the"infection"site"[5]."Echtenacher"et"al."[6],"demonstrated"





innate" immune" cell" recruitment,"MCs" can"participate" in" innate" defense" through"






MCEdeficient"mouse"model" was" used" in"many" studies" to" elaborate"MC" role" in"
adaptive"immunity."Previous"studies"[10,"11],"demonstrated"that"T"cell"activation"
was"impaired"in"MCEdeficient"mice"compared"to"controls."This"was"correlated"with"
a" reduction" in" dendritic" cell" migration" to" the" lymph" nodes" [10," 11]." Also," the"
production" of" chemokines" such" as"CCL20" by"MCs" probably" contributes" to"DC"
progenitors" recruitment" into" tissue" [12]." Furthermore," MCs" can" act" as" antigen"










these" occur" when" MCs" respond" inappropriately" to" innocuous" antigens."
Sensitization"occurs"with"the"initial"exposure,"but"the"clinical"manifestations"arise"
later"after" reEexposure" to" the"same"antigen."Moreover,"MCs"are" involved" in" the"
pathogenesis"of"other"chronic"inflammatory"diseases"such"as"chronic"periodontitis"
(CP)," chronic" urticaria" (CU)," and" atopic" dermatitis" (AD)." In" CP," the"
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periodontopathogenic" bacteria" trigger" the" immunopathologic" response"which" in"




MCEdeficient" mice" were" protected" against" Porphyromonas# gingivalis–induced"
alveolar"bone"loss"compared"to"WT"[16].""
Similarly," the" significant" role" of"MCs" in" patients" with" " CU" and" AD," was"
emphasized"by"the"increase"in"number"or"activity"in"the"affected"tissue"[17]k"and"
utilizing" antiEhistamine" and" MC" stabilizers" helped" in" alleviating" the" signs" and"
symptoms"of"CU"and"AD"[18,"19]."One"of"the"important"aspects"in"the"pathogenesis"
of"AD"and"CU"is"the"interaction"between"MCs"and"nerve"fibers."It"is"now"generally"












mediators" release" and" their" abundance" in" the" tissue." The" release" of" different"
preformed" granules" or" de" novo" production" of" mediators" depends" on" several"
molecular"pathways"that"are"determined"by"the"threshold"and"magnitude"of"MCs"
activation"[27,"28]."The"cytoplasmic"granules"contain"biogenic"amines"(histamine),"
proteases" (tryptase" and" chymase)," lysosomal" enzymes" (βEhexosaminidase),"
cytokines"(TNF"and"SCF),"and"proteoglycans"(heparin"and"chondroitin"sulfates)"
[28E32]." MCs" express" a" vast" array" of" cell" surface" receptors" that" regulate" MC"
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activation,"migration,"and"proliferation."At"the"initial"activation"of"MCs,"they"release"
a" large" quantity" of" lipidEderived" inflammatory" mediators." Later" after" initial"
stimulation," activation" of" transcriptional" factors" result" in" enhancement" of" gene"
expression"of"a"variety"of"cytokines"that"have"different"effects"on"the"surrounding"
or"distal"environment"[33].""




highEaffinity" IgE" receptor" (Fc!RI)" depends" on" the" antigen" concentration" and"
affinity." In" low"concentration"of"antigen," it" results" in"more"chemokine"production"
without" degranulation."Whereas"high"antigen" concentration" or" affinity" results" in"
both"chemokine"production"and"degranulation"[34]."This"is"due"to"the"ability"of"the"
MCs"to"trigger"different"signaling"cascades"based"on"the"nature"of"the"stimuli"even"




help" in" restoring"homeostasis"at" the" infection"sites"after"pathogen"clearance" to"
prevent"excessive"inflammation"and"facilitate"wound"healing."
There"are"two"categories"of"MCs"based"on"their"granule"proteases"content."










Besides" Fc!RI," MCs" express" several" G" proteins" coupled" receptors"
(GPCRs)"which"are"characterized"by"seven"transmembrane"(7TM)"domains,"and"
as"the"name"implies,"are"associated"with"heterotrimeric"G"proteins"that"coupled"to"
the" intracellular"domains"of" the"receptor."GPCRs"constitute" the" largest"class"of"
receptors"in"eukaryote"[39]."Recently"it"has"been"shown"that"a"diverse"group"of"
amphipathic" cationic" peptides" such" as" HDPs," NPs" and" FDA" approved" drugs"
activate" MCs" through" a" MasErelated" GPCR" known" as" MRGPRX2" [40E42]." As"
opposed"to"many"other"G"proteinEcoupled"receptors,"MRGPRX2"has"been"shown"
to" be" predominantly" expressed" in" MCs" [43]." Among" the" five" superfamilies" of"
GPCRs,"MRGPRX2"belong"to"the"rhodopsin"family,"or"class"A,"which"comprises"
85%"of"the"entire"superfamily"[44].""









in" Mrgprb2"mutated" PMCs" [40]." Therefore,"Mrgprbrb2" is" considered" to" be" the"
mouse"ortholog"of"the"human"MRGPRX2."
MRGPRX2"and"Mrgprb2"are"expressed"predominantly"in"MCTC"and"CTMC,"
respectively." Although" they" are" now" considered" as" the" basic" secretagogue"
receptor"in"MCs,"they"do"have"differences"with"respect"to"agonist"concentration"
required" for" their" activation." EC50"values" (concentration" required" to" give" 50%"
response)" of" most" of" the" ligands" are" lower" for" MRGPRX2" than" in" the"murine"
Mrgprb2."For"instance,"48/80"EC50"value"for"human"MC"is"470"nM,"whereas"murine"
MC"require"3.5"µM"[40,"45]."This"difference"in"concentration"could"be"attributed"to"
the" difference" in" amino"acid" sequence"between" the" two" receptors." The"overall"
sequence" similarity" is" only" #53%k" with" NEterminal" and" CEterminal" sequence"
similarity"at"only"#34%"and"#47%"sequence"similarity,"respectively."According"to"
homology" modeling" studies" of" different" GPCR," extracellular" (EC)" and"





In" the" following" chapters," I" will" discuss" the" role" of" MRGPRX2" in" host"









































1-Specific Aim 1: To determine if non-cytotoxic synthetic smHDPMs that 




2-Specific Aim 2: 
•" 2A: To determine MRGPRX2 expression in human skin MCs in rosacea and 
to modulate experimental rosacea model by targeting Mrgprb2 in vivo. 
 
•" 2B: To determine the role of STIM1/Orai calcium channel on MRGPRX2 
mediated mast cells activation and degranulation. 
"
"
3-Specific Aim 3: To identify the structural components of MRGPRX2 which 








Chapter 2: Small-Molecule Host-Defense Peptide Mimetic 
antibacterial and antifungal agents activate human and mouse 
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!HostEdefense" peptides" (HDPs)" have" an" important" therapeutic" potential"
against"microbial"infections"but"their"metabolic"instability"and"cellular"cytotoxicity"
have" limited" their" utility." To" overcome" these" limitations," we" utilized" five" smallE
molecule," nonpeptide" HDP" mimetics" (smHDPMs)" and" tested" their" effects" on"
cytotoxicity,"antimicrobial"activity,"and"mast"cell"(MC)"degranulation."None"of"the"









tissue"MCs" (CTMCs)" such" as" cutaneous" and" peritoneal" MCs" (PMCs)." All" five"
smHDPMs"induced"degranulation"in"wildEtype"PMCs"but"not"in"cells"derived"from"









reactions," their"most" important" functions" likely" include" tissue"homeostasis,"host"






and"are"referred" to"as"connective" tissue"MCs"(CTMCs)"but" lung"MCs"resemble"
human" MCT" and" are" known" as" mucosal" MCs" (MMCs)." Interestingly," CTCMs"
contain"abundant"heparin"in"their"granules"but"MMCs"do"not."







(lung," gut)," are" induced" by" TEcellEdependent" inflammation," and" do"not" express"
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MRGPRX2/Mrgprb2" [37," 40," 43]." It" has" been" proposed" that" innate/constitutive"
MCs" contribute" to" tissue" homeostasis" and" host" defense" to" bacterial" infection"
through" their" degranulation" and" the" subsequent" recruitment" of" neutrophils" and"
dendritic"cells"[6,"50,"54E56]"
Infections" by" fungal" organisms" are" associated" with" a" wide" spectrum" of"
diseases" ranging" from" acute" selfElimiting" manifestations" in" immunocompetent"
individuals"to"allergy"and"severe"lifeEthreatening"infections"in"immunocompromised"
patients"[57]."Recently,"there"has"been"a"tremendous"increase"in"the"incidence"of"
fungal" infection," which" is" attributed" to" the" overuse" of" prophylactic" antifungal"
therapy"and" increased"resistance" to" these"drugs" [58E60]."Antibiotics"have"been"
used"for"treatment"of"bacterial"infections"since"the"early"1900s"but"the"emergence"
of" multidrugEresistant" strains" of" microbes" poses" a" tremendous" public" health"
concern"globally"[61]."Thus,"there"is"an"urgent"need"to"develop"a"novel"therapy"for"
the" treatment" of" fungal" infection" and" infection" caused" by" antibioticEresistant"
bacteria.""
Antimicrobial" peptides" (AMPs)," also" known" as" hostEdefense" peptides"
(HDPs),"represent"an"evolutionarily"ancient"mechanism"of"innate"immunity"found"
in" both" animal" and" plant" kingdoms" [62E64]." These" peptides" are" cationic"
amphiphiles" and" provide" protection" against" a" variety" of" organisms" including"
bacteria," fungi," and" parasites" [63," 65]." The" cationic" charge" on" HDPs" provides"
electrostatic" attraction"with" the" anionic" surface"of"microbial"membrane"and" the"




















toxicity." Furthermore," these" compounds" exhibit" potent" activity" against" both"
bacteria" and" fungi" [73]." However," the" possibility" that" smHDPMs" harness"MCs’"
immunomodulatory" properties" via" inducing" their" degranulation" has" not" been"
tested."
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The" purpose" of" this" study" was" to" determine" if" noncytotoxic" synthetic"








HDP," human" $EdefensinE3" [75]." We" also" sought" to" determine" the" effects" of"
MRGPRX2" missense" mutation" on" MC" activation" by" smHDPMs." The" data"
presented"herein"suggest"that"smHDPMs"that"harness"MCs’"immunomodulatory"
properties" may" serve" as" novel" antifungal" and" antibacterial" agents." However,"











C57BL/6" (WT)" mice" were" obtained" from" the" Jackson" Laboratory" (Bar"
Harbor,"ME)."Mrgprb2E/E"mice"in"C57BL/6"background"were"generated"by"CRISPRE
Cas9"mediated"deletion"of"Mrgprb2"in"CRISPRECas9"core"facility"of"the"University"
of" Pennsylvania." Four" pairs" of" guide" RNA" (GR1:" CaccGCT"
GCTCCTATTCTGGTCAGG" GGG" and" AaacCCTGACCAGAATAGGAGCAGCk"
GR2:" Cacc" GACACTGAGTGTCTATATGG" AGG" and"
AaacCCATATAGACACTCAGTGTCk"GR3:"Cacc"GGTTGTAAAAATGGTCCACA"
CGG" and" AaacTGTGGACCATTTTTACA" ACCk" GR4:"
CaccGAATACTTTTTCTTATCCGTG" TGG" and" AaacCACGGATAAGAA"









Mice" were" housed" in" pathogenEfree" cages" on" autoclaved" hardwood"
bedding."SevenE"to"twelveEweekEold"male"and"female"mice"were"used"in"this"study."
All" experiments" were" approved" by" the" Institutional" Animal" Care" and" Use"
Committee"at"The"University"of"Pennsylvania.!
Materials 
!All" cell" culture" reagents" and" DNPEspecific" mouse" IgE" (SPEE7)" were"
purchased"from"Invitrogen"(Carlsbad,"CA)."Recombinant"murine"interleukinE3"(ILE
3)," stem"cell" factor" (SCF)," and" recombinant"human"SCF"were"purchased" from"
Peprotech" (Rocky" Hill," NJ)." DNPEBSA" and" pEnitrophenylENEacetylEβEDE
glucosamine"(PNAG)"were"from"SigmaEAldrich"(St."Louis,"MO),"Compound"48/80"
was"from"AnaSpec"(Fremont,"CA)."Amaxa"transfection"kit"(Kit"V)"was"purchased"
from" Lonza" (Gaithersburg," MD)." PE" antiEhuman" MRGPRX2" antibody" was"
purchased" from" Biolegend" (San" Diego," CA)." Polyclonal" MRGPRX2" Ab" was"
purchased"from"Novus"Biologicals"(Littleton,"CO)."HRPEconjugated"antiErabbit"IgG"
was" from" Cell" Signaling" Technologies" (Danvers," MA)." West" Pico"
Chemiluminescent"Substrate"was"from"Thermo"Scientific"(Rockford,"IL)."DNeasy!
Blood" and" Tissue" Kit" was" purchased" from" Qiagen" (Germantown," MD)."
QuikChange" II" SiteEDirected" Mutagenesis" Kit" was" purchased" from" Agilent"
Genomics" (Santa" Clara," CA)." Plasmid" encoding" hemagglutinin" (HA)Etagged"
human"MRGPRX2" in" pReceiverEMO6" vector" was" obtained" from"GeneCopoeia"
(Rockville," MD)." Antimicrobial" peptidomimetics" (compound" 1," compound" 2,"
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compound" 3," compound" 4," and" compound" 5)" were" obtained" from" Fox" Chase"
Chemical"Diversity"Center"(Doylestown,"PA).""
Fungus MIC assay 
Fungal" strains" included" a" clinical" isolate" of" Candida# albicans# (ATCC"
GDH2346)," Aspergillus" fumigatus" (ATCC" MYAE3626)," and" Aspergillus" flavus"
(ATCC"204304)."Minimum"inhibitory"concentration"(MIC)"assays"were"carried"out"
in" 96Ewell" plates" using" the" Clinical" and" Laboratory" Standards" Institute" (CLSI)"
method" C27EA3" for" C.# albicans" and" M38EA2" for" Aspergillus" species" [32]."
smHDPMs," each" in" stock" solutions" of" 10"mM" in"DMSO,"were" diluted" in" 50" µl"
RPMI/MOPS"pH"7.0"in"a"96Ewell"plate"and"50"µl"of"diluted"yeast"were"added"to"
each"well."Final"DMSO"concentrations"in"the"assay"did"not"exceed"1%."The"plate"
was" then" incubated" at" 35°C" for" 48" h." The"MIC"was" determined" as" the" lowest"
concentration"of"an"antimicrobial"agent"that"substantially"inhibits"the"growth"of"the"
organism."All"MIC"assays"were"performed"in"duplicate.""
Bacterial MIC assay 
smHDPMs" were" tested" for" antibacterial" activities" against" three" GramE




adjusted"Mueller–Hinton"medium" was" inoculated" with" 20" µl" of" frozen" bacterial"
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stock" and" incubated" at" 37" °C" on" a" shaker" platform" (250" rpm)" overnight." The"















Cytotoxicity" (50%" effective" concentration," CC50)" was" determined"against"
mouse"3T3" fibroblasts" (ATCC"CRLE1658)" and"human" transformed" liver"HepG2"
cells" (ATCC" HBE8065)" using" an" MTS" viability" assay" according" to" the"
manufacturer's" protocol" (Promega" CellTiter" 96" aqueous" nonradioactive" cell"






five" compounds" were" added." Compound" stock" solutions" were" prepared" in"
methanol" and" final"methanol" concentrations" in" the" assay" did" not" exceed" 10%."
Following"incubation"for"1"hour"at"37"°C,"compound"solutions"were"removed"and"
medium"containing"serum"was"replenished."Viability"was"determined"by"addition"
of" the" tetrazolium"compound,"MTS,"and" the"electron"coupling"agent,"PMS,"and"
then"incubation"at"37"°"C"for"2"hours"(3T3"cells)"or"3"hours"(HepG2"cells)"followed"
by" absorbance"measurements" at" 490" nm" [78]." The"CC50"was" calculated" using"
GraphPad"Prism"software"(nonlinear"fit)."
Mast cell culture 
The"human"mast"cell"line,"LAD2,"was"maintained"in"complete"StemProE34"
medium" supplemented" with" LEglutamine" (2" mM)," penicillin" (100" IU/ml),"
streptomycin" (100" μg/ml)," and" 100" ng/ml" recombinant" human" stem" cell" factor"
(rhSCF)." Hemidepletions"were" performed"weekly"with"media" containing" rhSCF"
(100" ng/ml)" [79]." Rat" basophilic" leukemia" (RBLE2H3)" cells" were"maintained"as"
monolayer"cultures"in"DMEM"supplemented"with"10%"FBS,"LEglutamine"(2"mM),"
penicillin" (100" IU/ml)," and" streptomycin" (100"µg/ml)" [80]." Peritoneal"mast" cells"
(PMCs)" were" obtained" from" 6–8" weeks" C57BL/6" and" Mrgprb2E/E" (C57BL/6"
background)"mice"using"i.p."injection"of"8"ml"MC"disassociation"medium"that"was"
made" of" HBSS" with" 3%" FCS" and" 10"mM"HEPES." The" cells" were" cultured" in"
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Iscove's" Modified" Dulbecco's" Medium" (IMDM)" supplemented" with" 10%" FCS,"







Lentivirus-mediated knockdown of MRGPRX2 in LAD2 cells 
Lentivirus" generation" was" performed" in" HEK293T" cells" as" per"






Western blotting to determine MRGPRX2 expression 
Cell"lysates"were"prepared"from"scrambled"control"and"MRGPRX2"shRNA"
transduced"LAD2"cells"in"RIPA"buffer"and"protein"was"quantified"using"BCA"protein"
assay" kit" (Thermo" Scientific)." Protein" was" separated" in" SDSEPAGE" (10" %),"















RBLE2H3" cells" (5" ×" 104)," LAD2" cells" (10" ×" 104)," and" PMCs" (5" ×103),"
BMMCs" (5" ×" 104)," were" seeded" into" 96Ewell" plates" in" a" total" volume" of" 50" μl"
HEPES" buffer" containing" 0.1%" bovine" serum" albumin" (BSA)" and" exposed" to"
ligands"for"30"minuts."Cells"without"treatment"were"designated"as"control."In"some"





stopped" by" adding" 250" μl" of" a" 0.1" M" Na2CO3/0.1" M" NaHCO3" buffer" and"
absorbance"was"measured"at"405"nm."
Statistical analysis 
Data" shown" are" mean" ±" SEM" values" derived" from" at" least" three"






Antifungal and cytotoxic activities of smHDPMs (compounds 1, 2, and 3) 




and" hydrophobic" groups" segregate" into" the" opposite" sides" of" the" molecular"
backbone."It"is"thought"that"positive"charges"on"the"HDPs"and"anionic"surface"of"
microbial" membrane" provide" recognition" and" the" subsequent" hydrophobic"
interaction"perturbs"membrane"structure"and"function" leading" to"microbial"death"







Minimal" inhibitory" concentrations" (MICs)" against" Candida# albicans,#
Aspergillus# fumigatus," and" Aspergillus# flavus" were" determined." Compound" 2"
showed"the"highest"antifungal"activity"with"MIC"value"of"0.39"µg/ml."Compound"1"
exhibited"moderate"antifungal"activity"against"Aspergillus#fumigatus"with"MIC"value"
of" 12.5–50" µg/ml" but" potent" activity" against"Candida# albicans" and" Aspergillus#
flavus" with" MIC" values" between" 0.78" µg/ml" and" 6.25" µg/ml." By" contrast,"
Compound"3"displayed"poor"antifungal"activity"with"MIC">"100"µg/ml"(Fig.""1B)."In"
order" to"determine" the"cytotoxicity"of"smHDPMs,"we"used"two"cell" lines"HepG2"
and"3T3"cells"and"measured"CC50"values."Compound"3"displayed"cytotoxicity"at"
concentrations" similar" to" those" required" for" antifungal" activity." However," at"
concentrations" that" are" relevant" for" antifungal" activity," Compounds" 1" and" 2"
displayed"little"to"no"cytotoxic"effects"on"3T3"and"HepG2"cells"(Fig.""1B)."
smHDPMs (Compounds 1, 2, and 3) activate human MCs via MRGPRX2 
To" determine" if" smHDPMs" that" display" differences" in" antifungal" activity"




had" antifungal" activity" (Fig." " 1A)," all" three" compounds" induced" robust" $E
hexosaminidase"release"(Fig.""2A)."
To" determine" if" the" effects" of" these" compounds" are" mediated" via" the"
activation"of"Gαi"family"of"G"proteins,"we"incubated"cells"with"pertussis"toxin"(PTx)."
As" shown" in" Fig." " 2A," degranulation" in" response" to" all" three" compounds" was"
substantially" inhibited" by" PTx," indicating" the" involvement" of" G" proteins." HDPs"
induce"degranulation"in"human"MCs"via"MRGPRX2"[62,"65,"69]."To"determine"if"
these" compounds" also" activate" human" MCs" via" MRGPRX2," we" silenced" its"
expression"in"LAD2"cells"with"lentiviral"shRNA."Compared"to"the"controlEshRNA"
transduction,"MRGPRX2EshRNA"transduction"resulted" in"a"substantial" reduction"
of" MRGPRX2" expression" as" demonstrated" by" Western" blotting" (Fig." " 2B)."
Furthermore," degranulation" induced" by" all" three" compounds" was" significantly"
inhibited" in" MRGPRX2Esilenced" cells" when" compared" to" control" shRNA"
transduced"cells"(Fig.""2C)."RBLE2H3"is"a"rodent"MC"line"that"has"been"used"to"
study" IgEEmediated" responses" in" vitro." Unlike" LAD2" cells," it" does" not" express"
MRGPRX2"and"is"unresponsive"to"its"ligands."We"therefore"used"RBLE2H3"cells"
stably" expressing"MRGPRX2" to" confirm" the" role" of" this" receptor" on" smHDPME
induced"responses"in"MCs."As"shown"in"Fig.""3A,"all"compounds"(3"µM)"induced"
40–50%" degranulation" in" MRGPRX2Eexpressing" cells" but" not" in" untransfected"
cells." RBLE2H3" cells" expressing"MRGPRX2"were" used" to" determine" the" EC50"
value" for" the" smHDPMs."The"EC50" values"were"0.8"µM," 3"µM," and"1.8"µM" for"
Compound"1,"2,"and"3,"respectively"(Fig.""3,"B–D)."
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Effects of Compounds 2, 4, and 5 on antibacterial activity and MC 
degranulation 
We"subsequently"selected"the"most"potent"antifungal"compound"and"its"two"
derivatives" for" antibacterial" screening" against" an" array" of" bacteria" (Fig." " 4A)."
Compound" 2" showed" potent" antibacterial" activities" against" one" GramEnegative"
bacteria,"Escherichia# coli," and" GramEpositive" bacteria,"Staphylococcus# aureus,"
with"MIC"values"of"3.1"and"0.1"µg/ml,"respectively,"which"can"be"correlated"with"
its" potent" antifungal" activity" (Fig." " 4B)." However," this" compound" showed" poor"
antibacterial" activity" against"Klebsiella# pneumoniae,"Pseudomonas# aeruginosa,"
and#Enterococcus#faecalis.""
Two"derivatives"of"Compound"2"(Compound"4"and"Compound"5)"showed"

















finger" nucleaseEbased" strategy" to" generate" a" mouse" line" with" fourEbaseEpair"
deletion" in" Mrgprb2" coding" region" (Mrgprb2MUT)." For" our" studies," we" used"
CRISPR/Cas9" technology" to" delete"Mrgprb2" in" C57BL/6"mice." Deletion" of" the"
Mrgprb2"was"confirmed"by"genotyping"(Fig.""6A)."Furthermore,"as"expected,"the"
absence" of" Mrgprb2" in" mouse" PMCs" had" no" effect" on" antigen/IgEEmediated"
degranulation" (Fig." " 6B)" but" almost" completely" abolished" the" response" to"
compound"48/80,"a"polymer"known"to"activate"MCs"via"Mrgprb2"(Fig.""6C)."All"five"
smHDPMs" induced" degranulation" in" wildEtype" PMCs" but" this" response" was"
abolished"in"PMCs"derived"from"Mrgprb2E/E"mice."BMMCs,"which"do"not"express"
Mrgprb2"[40],"did"not"respond"to"compound"48/80"or"any"of"the"smHDPMs"tested"
despite" their"normal" responsiveness" to"antigen/IgE"for"degranulation"(Fig." "6D)."




Naturally occurring missense MRGPRX2 variants D184H, G165E are 
resistant to activation by smHDPMs  
G" proteinEcoupled" receptors" contain" 7Etransmembrane" bundles" that" are"




TM" regions" have" the" greatest" structural" diversity" and" are" responsible" for" the"
binding" of" diverse" ligands." By" contrast," the" IC" and" its" closest" TM" regions" are"




ligands" including" the" HDP," human" βEdefensinE3" [75]." We" therefore" sought" to"
determine"if"these"variants"display"lossEofEfunction"phenotype"for"MC"activation"by"
smHDPMs."For"this,"RBLE2H3"cells"were"transfected"with"cDNAs"encoding"wildE
type," D184H," and"G165E" variants." Flow" cytometry" analysis" demonstrated" that"
wildEtype"and"mutant" receptors"are"expressed"on" the"cell" surface"at"equivalent"















there" is"an"urgent"need"to"develop"novel" therapy" for" the" treatment"of" infections"
caused" by" drugEresistant" microbes." HDPs" have" important" therapeutic" potential"
against"bacterial," viral,"and" fungal" infections"but" their"metabolic" instability,"poor"
tissue" distribution," and" cellular" cytotoxicity" have" limited" their" utility" [70," 71]." To"
overcome" these" limitations," synthetic" smHDPMs" have" been" developed," which"
display" broadEspectrum" antimicrobial" activity" both" in# vitro" and" in# vivo" with" low"
cytotoxicity" [78," 83E86]." Based" on" these" findings," it" has" been" proposed" that"
smHDPMs"could"be"developed"as"a"new"class"of"antifungal"agents"and"antibiotics."
The"data"presented"herein"raise"the"interesting"possibility"that,"in"addition"to"their"




Although" MCs" have" been" strongly" implicated" in" antifungal" host" defense," their"
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mechanisms"remain"largely"unknown"[87,"88]."Fungal"keratitis"(FK),"also"known"
as" keratomycosis" or" mycotic" keratitis," is" an" infection" caused" by" opportunistic"
Fusarium,"Aspergillus,"and"Candida#albicans,#which"are"difficult"to"treat"and"may"
eventually" require"surgery# [89,"90].#MCs" found" in" the"corneal" limbus"are"of" the"
connective"tissue"(innate)"type"and"they"undergo"degranulation"in"a"mouse"model"
of"FK,"resulting"in"vasodilation,"increased"intercellular"adhesion"moleculeE1"(ICAME
1)" expression" on" endothelial" cells," and" neutrophil" infiltration" [91]." Interestingly,"
stabilization"of"MCs"with"cromolyn"leads"to"inhibition"of"MC"degranulation,"dramatic"





The"mechanism" via" which" corneal"MCs" undergo" degranulation" in" FK" is"
unknown"but" a" role" of" neuropeptides" has"been"proposed" [91]."MRGPRX2"and"
Mrgprb2"are"expressed"predominantly" in"human"and"murine"MCs,"respectively,"
and"are"not"found"in"any"other"immune"or"structural"cells"[40,"43,"92,"93]."Given"
that" neuropeptides" such" as" SP" induce" degranulation" in" MCs" via"
MRGPRX2/Mrgprb2," this" raised" the" interesting" possibility" that" this" receptor"
contributes"to"the"role"of"MCs"in"host"defense"to"fungal"corneal"infection"[40,"43,"
94]." It" is" noteworthy" that" in" addition" to" histamine" and" proteases,"MC" granules"
release"HDPs"during"degranulation,"which"further"induces"MC"degranulation"via"
MRGPRX2" [8," 67," 92," 95]." These" findings" are" consistent" with" the" notion" that"
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noncytotoxic" smHDPMs" that" display" both" antifungal" activity" and" harness"MCs’"
immunomodulatory"function"may"serve"as"a"new"class"of"antifungal"agents.""
Our" initial" screen"utilized" three" structurally" related" smHDPMs."We" found"
that" Compounds" 1" and" 2" displayed" antifungal" activity" against" C.# albicans," A.#
fumigitus,"and"A.#flavus#with"Compound"2"being"more"potent"than"Compound"1,"











not" BMMCs" supports" our" contention" that" these" agents" activate" CTMCs" via"
Mrgprb2." This" contention" was" confirmed" by" the" demonstration" that" these"
compounds"did"not"induce"degranulation"in"PMCs"obtained"from"Mrgprb2E/E"mice."
These"findings"suggest"that"two"of"the"three"smHDPMs"used"in"our"initial"screen"
display" both" direct" antifungal" activity" and" harness" MCs’" immunomodulatory"
property" by" inducing" their" degranulation" and" could" serve" as" novel" antifungal"
agents.""
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[40]." Arifuzzaman" et" al." [50]" recently" showed" that" mastoparan" induces"
degranulation" in" mouse" CTMCs" to" promote" neutrophil" recruitment," which"
accelerates" bacterial" (S.# aureus)" clearance" in" infected" skin." Interestingly," a"
mastoparan" derivative" that" does" not" induce" MC" degranulation" but" retains" its"
antimicrobial"activity"against"S.#aureus"is"ineffective"in"clearing"skin"infection."By"
contrast,"a"mastoparan"derivative"devoid"of"antimicrobial"activity"against"S.#aureus"




dendritic" cells" (DCs)" promote" reEepithelialization" of" sterile" wounds" and" their"
numbers"are"decreased"in"S.#aureus+infected"skin"[50,"96]."However,"MCs"promote"
reEepithelialization" by" restoring" the" skin" CD301b+" DC" population." In" addition,"










difference," all" three" compounds" induced" degranulation" in" LAD2" cells" via"
MRGPRX2" and" murine" PMCs" via" Mrgprb2." Thus," similar" to" the" case" with"
mastoparan" [50],"Compounds"4" and"5"may"promote"S.# aureus" clearance" from"








bacterial"clearance"and"skin"regeneration" in"vivo." It" is" likely" that"smHDPMs"will"
promote"these"responses"at"lower"concentrations"than"mastoparan."Brilacidin,"a"
smHDPM"structurally"similar"to"the"compounds"used"in"the"present"study,"is"being"
developed"for" the" treatment"of"acute"bacterial"skin" infection" [71]."Brilacidin"also"
displays" efficacy" in" a" rabbit" model" of" methicillinEresistant" S.# aureus# (MRSA)E
induced"keratitis"[97]."Based"on"the"data"presented"in"this"study,"and"the"in#vivo"
findings" with" mastoparan" and" its" analogs" [50]," it" is" possible" that" the" potential"
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clinical" utility" of" brilacidin" reflects" its" ability" to" activate" MCs" via" MRGPRX2" in"
addition"to"its"direct"antimicrobial"activities.""






skin" promotes" both" bacterial" clearance" and" skin" regeneration" without" any"
noticeable" side" effects" at" the" application" site" or" systemically" [50]." Third," two"
peptide"antibiotics"approved"by"the"US"Food"and"Drug"Administration,"polymyxin"
B"and"colistin,"activate"MCs"but"do"not"induce"anaphylaxis"in"patients"[50,"98]."One"
important" finding" of" the" present" study" was" that" MCs" expressing" missense"
MRGPRX2" variants" G165E" (rs141744602)" and" D184H" (rs372988289)" were"
resistant" to"degranulation" in" response" to"all"smHDPMs" tested" [75]."Thus," if" the"
potential" clinical" utility" of" smHDPMs" reflects" their" ability" to" activate" MCs" via"
MRGPRX2,"individuals"harboring"these"mutations"may"be"resistant"to"this"type"of"
therapy."""
In"conclusion,"we"found"that" five"smHDPMs"with" low"cytotoxicity" induced"
degranulation"in"human"MCs"via"MRGPRX2"and"murine"MCs"via"Mrgprb2."These"












Fig.  1: Structure and antifungal activity of three smHDPMs compounds (Cpd). 































Fig.  2: smHDPMs activate human mast cells via MRGPRX2.  
(A),"LAD2"cells"pretreated"with"or"without"pertussis"toxin"(PTx,"100"ng/ml,"
16h)"were"exposed"to"vehicle"(Control)"or"smHDPMs"compounds"(Cpd)"1,"
2," and"3" (3" µM"each)" for" 30"min" and"percentage"of" βEhexosaminidase"
release"was"measured."(B),"Western"blotting"was"performed"to"determine"
the"expression"level"of"MRGPRX2"in"Control"and"MRGPRX2"knockdown"
LAD2" cells." (C)," Control" and" knockdown" cells" were" stimulated" with"
smHDPMs" Cpd" 1," 2," and" 3" (3" µM" each)" and" percentage" of" βE
hexosaminidase"release"was"determined."All"the"points"are"expressed"as"
a"mean"±"SEM"of" three"experiments" in" triplicate."Statistical"significance"













Fig.  3: smHDPMs induce degranulation in RBL-2H3 cells expressing MRGPRX2.  
(A),"Untransfected"RBLE2H3"cells"(RBLE2H3)"and"cells"stably"expressing"
MRGPRX2" (RBLE2H3EMRGPRX2)"were"exposed" to"vehicle" (Control)"or"
smHDPMs," (Cpd" 1," 2," and" 3," 3" µM)" for" 30"min" and" percentage" of" βE
hexosaminidase"release"was"determined.!Concentration–response"curves"
for"!(B),"Cpd"1,"(C),"Cpd"2,"and"!(D),"Cpd"3"were"determined"using"RBLE
2H3EMRGPRX2" cells." Data" are" presented" as" a" mean" ±" SEM" and" are"
















Fig.  4. Structure and antibacterial activity of three smHDPMs compounds. 
"!(A),"Structure"of"compound"(Cpd)"2"and"two"of"its"derivatives,"Cpd"4"and"
Cpd" 5." (B)," " Minimum" inhibitory" concentration" (MIC)" values" (μg/ml)" of"























Fig.  5: Compound 4 and Compound 5 induce degranulation in RBL-2H3 cells 
expressing MRGPRX2.  
(A),"Untransfected"RBLE2H3"cells"(RBLE2H3)"and"cells"stably"expressing"
MRGPRX2" (RBLE2H3EMRGPRX2)" were" exposed" to" vehicle" (Control),"
smHDPMs"compound"(Cpd)"4,"and"Cpd"5"(3"µM"each)"for"30"minutes"and"
percentage"of"βEhexosaminidase"release"was"determined."Concentration–
response"curves" for" ! (B),"Cpd"4"and" ! (C),"Cpd"5"were"performed"using"
RBLE2H3EMRGPRX2"cells."Data"are"presented"as"mean"±"SEM"and"are"



















Fig.  6: smHDPMs induce degranulation in PMCs via Mrgprb2."!
(A),"Genotyping"of"wildEtype"(WT)"and"Mrgprb2E/E"by"PCR"using"Mrgprb2E
specific"primers.# (B),"PMCs" isolated" from"WT"and"Mrgprb2E/E"mice"were"
exposed" to" IgE" (1" µg/ml," 16" houres)" and" then" stimulated" with" antigen"
(DNPEBSA,"100"ng/ml,"30"minutes)"and"βEhexosaminidase" release"was"
determined."(C)"PMCs"were"stimulated"with"compound"48/80"(10"µg/ml)"
or" smHDPMs" (Cps" 1–5," 10" µM)" for" 30"minutes" and" βEhexosaminidase"
release"was"determined.!(D),"BMMCs"were"exposed"to"IgE"(1"µg/ml,"16"
hours)" and" stimulated" with" antigen" (DNPEBSA," 100" ng/ml)," 48/80" (10"
µg/ml),"smHDPMs"(10"µM)"for"30"minutes"and"βEhexosaminidase"release"
was" determined." All" the" points" expressed" as" a" mean" ±" SEM" of" three"












Fig.  7: Missense MRGPRX2 variants do not respond to smHDPMs for 
degranulation.!!
(A)," RBLE2H3" cells" were" transiently" transfected" with" cDNA" encoding"
MRGPRX2" or" its" missense" variants" D184H" and" G165E." Receptor"
expression"was"determined"by" flow"cytometry"using"antiEMRGPRX2EPE"
antibody." (B)," RBLE2H3" expressing" MRGPRX2" variants" (D184H" and"
G165E)"were"stimulated"with"smHDPMs"(Cpds"1–5,"3.0"µM)" for"30"min"
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MCEdeficient" Wsh/Wsh" mice" in" a" murine" model" of" rosacea." We" found" that"
intradermal"injection"of"LLE37"resulted"in"the"development"of"erythema"in"WT"mice,"






infiltration" in" Mrgprb2E/E" and" Wsh/Wsh" mice" when" compared" to" WT" mice." Ca2+"
mobilization" is"prerequisite" for"MC"activation"and" thus"calcium"channel"plays"a"
crucial" role" in"MCEinduced"pathogenesis."We"used" freshly" isolated"skin"MCs" to"
identify"the"role"of"Orai"Ca2+"channel"in"MRGPRX2Emediated"MC"activation."We"
found"that"Orai"channel"inhibitors"caused"significant"decrease"in"LLE37"and"SPE
induced" degranulation" in" human" skin"MCs" as"well" as" human"MC" line" (LAD2).""
Furthermore," shRNA"mediated" knockdown"of"Orai1" and" its" upstream"molecule"
STIM1" led" to" significant" reduction" in" LLE37" and" SPEinduced" Ca2+" influx" and"
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that" mainly" affects" the" facial" skin." The" pathophysiology" of" rosacea" is" not" fully"
understood"but"it"is"likely"associated"with"dysregulation"of"the"immune,"vascular,"
and" nervous" systems" [99]." Expression" of" the" cathelicidin" LLE37" is" significantly"
increased"in"all"subtypes"of"rosacea"[100]."Also,"there"is"an"increased"expression"
of"the"epidermal"trypsinElike"serine"protease"enzyme,"kallikerin"5"(KLK5)"in"rosacea"
skin." This" enzyme" is" responsible" for" cleaving" the" inactive" precursor" protein"
(hCAP18)" to" the" biologically" active" LLE37" [101]."Besides" its" direct"antimicrobial"
activity," LLE37" also" has" proinflammatory" and" angiogenic" properties" which"
exacerbate"rosacea"[102]."Skin"is"highly"innervated"with"nerve"fibers"that"have"the"
ability" to" release" many" neuronal" proinflammatory" mediators" upon" central" or"
peripheral"stimulation"[103]."Cevikbas"et"al."[104],"showed"that"neuropeptides"such"
as" substance" P" (SP)" released" by" the" stimulation" of" nerve" endings" cause" the"
development" of" skin" lesions" that" resemble" clinical" and" histologic" features" of"
rosacea."These" findings"suggest" that"LLE37"and"SP"play" important" roles" in" the"
pathogenesis"of"rosacea.""
Recent"studies"have"strongly" implicated"MCs" in" rosacea" [100,"105E109]."
Thus,"the"number"of"MCs"in"rosacea"skin"is"increased"compared"to"normal"skin"
[105]."Furthermore,"Muto"et"al."[108],"showed"that"unlike"wildEtype"(WT)"mice,"MCE




further" indicating" the" pivotal" role" of"MCs" in" the" pathogenesis" of" rosacea."MasE
related" G" proteinEcoupled" receptor" (GPCR)" X2" (MRGPRX2)" is" a" seven"
transmembrane"domain"receptor"that"has"predominantly"expressed"in"a"subtype"
of" MCs" found" in" the" skin" [43]." Subramanian" et" al." [67]," provided" the" first"
demonstration" that" LLE37" activates" human" MCs" via" MRGPRX2." Although" SP"
induces" its" biological" responses" via" the" activation" of" neurokinin" receptors" in" a"
variety" of" cell" types," it" activates" human"MCs" via"MRGPRX2" [43," 45," 93," 110]."





receptor" on" the" wellEestablished" mouse" model" of" rosacea" have" not" been"
determined.""
Ca2+"mobilization"is"an"essential"requirement"for"the"MRGPRX2Edependent"

























!All" cell" culture" reagents" and" DNPEspecific" mouse" IgE" (SPEE7)" were"











and" HRPEconjugated" antiErabbit" IgG" was" from" Cell" Signaling" Technologies"
(Danvers,"MA)."West"Pico"and"femto"Chemiluminescent"Substrate"were"acquired"
from" Thermo" Scientific" (Rockford," IL)." DNeasy! Blood" and" Tissue" Kit" was"
purchased"from"Qiagen"(Germantown,"MD)."Collagenase"Type"2"was"purchased"
from"Worthington" Biochemical" Corporation" (Lakewood,NJ)." DNase" I" was" from"
Roche"Diagnostics"(Mannheim,"Germany)."Hyaluronidase"was"bought"from"Sigma"
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Immunohistochemistry" (IHC)" experiments" were" performed" using" normal"
and"rosacea"skin"samples"obtained"from"5"patients"in"order"to"evaluate"the"relative"
presence"and"the"abundance"of"MCs."Tryptase"was"used"as"a"MC"marker"for"this"
experiment." The" slides" are" archival" slides" from" Skin" Biology" and" Diseases"
ResourceEBased"Center" (SBDRC)."The" slides"were" heated" to" 55" oC"overnight,"








with" blocking" serum"using"normal"horse" serum" followed"by"monoclonal"mouse"




In" the" next" day," the" sections"were" then"washed"3" times"with"PBS/0.1%"
Tween" and" incubated" with" diluted" secondary" antibody," biotinylated" horse" anti"
mouse"IgG"for"one"hour"at"room"temperature."Following"secondary"Ab"incubation,"
the"slides"were"washed"3"times"in"PBS/0.1%"Tween"and"incubated"for"30"minutes"
with" Vectastain" ABC" reagent." Subsequently," they" were" washed" 3" times" in"
PBS/0.1%"Tween"and"incubated"in"NovaRed"peroxidase"substrate"solution"from"
a"DAB"peroxidase" substrate" kit" until" desired" color" intensity"was"observed."The"
slides"were"rinsed"under"running"tap"water"until"solution"was"clear"(approximately"
for" 5" minutes)," counterstained" in" Mayer’s" hematoxylin" solution" for" around" 2"
seconds"and"repeated"it"as"necessaryk"then"rinsed"again"in"running"tap"water"until"
excess"solution"was"removed."Rehydration"of"the"tissue"was"done"using"increasing"
graded" alcohol" series." Then" the" slides"were" cleaned"manually" histoclear" on" a"
cotton" tip" to" remove" the" hydrophobic" ring" and"moisture." The" slides"were" then"




Immunofluorescence" (IF)" experiments" were" performed" using" the" same"
samples"used"in"IHC"experiment"which"include"normal"and"rosacea"skin"samples"
that" were" obtained" from" 3" patients" in" order" to" evaluate" the" presence" of" any"







reagent" (Molecular" Probes)." Images" were" captured" on" a" Nikon" Eclipse" Ni"
microscope" with" an" Olympus" digital" microscope" camera" using" 20X" and" 60X"
magnifications."
 







Use" Committee" (IACUC)" of" the" University" of" Pennsylvania." WildEtype" mice"
(C57BL/6),"MCEdeficient" mice" (Wsh/Wsh)," and"MRGPRB2E/E"mice" were" used" for"
these" experiments." MRGPRB2E/E"mice" were" generated" via" CRISPR/Cas9" (see"
chapter2" for"more"details)."The"mice"were"shaved"24"hours"before" intradermal"
injection"with"50"μl"LLE37"(320"uM)"or" filtered"PBS"for"experimental"and"control"
groups" respectively," twice" a" day" for" 2" days."Dorsal" skin"was"evaluated" for" the"
degree"of"inflammation"and"then"excised"after"72"hours."The"excised"tissue"was"
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either" immersed" immediately" into"10%"formalin" for"histology"(Hemoxlyne/Eosin,"











Human Skin MCs Isolation 







































Lentivirus-Mediated Knockdown of STIM1 and Orai1 in LAD2  
STIM1" and" Orai1" targeted" mission" shRNA" lentiviral" plasmids" were"
















City," CA)" according" to" the" manufacturer's" protocol." Using" TaqMan" Gene"
Expression"Assays,"the!mRNA"expression"of"mouse"MMP+9"and"mouse"CXCL+2#
and# human"Orai1#was" analyzed# following" the"manufacturer’s" instructions.!The"
analysis"was"performed"in"triplicate"and!GAPDH#was"used"as"an"internal"control"
to"validate"RNA"for"each"sample."mRNA"expression"was"calculated"as"the"relative"








0.1%)." This" was" followed" by" incubation" with" HRP" conjugated" antiErabbit" IgG"




MRGPRX2-Tryptase double positive MCs are present in normal skin and 





and"dorsal"ganglia"but"not" in"other" immune"or"structural"cells" [43,"45,"118]."To"
compare" MRGPRX2" expression" in" normal" and" rosacea" skin," we" performed"








LL-37-induced MC degranulation is partially dependent on Mrgprb2 
Mrgprb2"has"been"identified"as"the"mouse"orthologue"of"human"MRGPRX2."




vitro" an" and# in# vivo" experiments" (Fig." 2"A)."Alcian/Safranin" staining"of" cultured"
PMCs"revealed"rich"heparin"content,"indicating"high"maturity"of"the"cell"population"
(Fig."2"B)."Antigen"(DNPEBSA,"10"ng/ml)"stimulation"of"both"WT"and"Mrgprb2E/E"
PMCs" shows" comparable" amounts" of" βEhexosaminidase" release" (Fig." 2" C)."
However,"βEhexosaminidase"release"after"stimulation"with"compound"48/80" (10"
ng/ml)" and"SP" (100"µM)"were" abolished" in"Mrgprb2E/E" PMCs" compared" to"WTE
PMCs"(Fig."2"D)."By"contrast,"LLE37"(10"µM)Einduced"degranulation"was"reduced"
by" ~50%" Mrgprb2E/E" PMCs" (Fig." 2" D)." This" suggests" that" LLE37" utilizes" both"
Mrgprb2Edepedent"and"independent"pathways"for"degranulation"in"mouse"MCs."""
Mrgprb2 partially contributes to LL-37-induced MC-dependent rosacea.   
Subcutaneous" injection" of" LLE37" induces" rosaceaElike" inflammation"
manifesting"as"a"local"erythema"at"the"injection"site"[119]."We"therefore"used"this"













MCs" possess" granules" that" occupy" the" majority" of" the" cytoplasm." The"
release"of"granules"filled"with"a"wide"variety"of"mediators," including"chemokines"
and" proteases," contributes" to" attracting" inflammatory" cells" and" rosacea"
development."MCs"produce"chemotactic"factors"such"as"CXCL+2"which"can"attract"
more"neutrophils"to"the"tissue"and"thereby"aggravate"the"inflammatory"reaction."
Moreover,"MMP+9" can" result" in" KLKE5" activation"which" in" turn" leads" to" further"




total" suggest"while"LLE37Einduced"rosacea" in"mice" is"entirely"dependent"on" the"
presence"of"MCs,"and"Mrgprb2"contributes"partially"to"this"response."
Substance P induced MMP-9 and CXCL-2 expression in WT mice but reduced 













Substance P and LL-37-induced degranulation is inhibited by Orai Ca2+ 
channel inhibitors in human skin MCs and LAD2 cells. 
Ca2+" influx" is" an" essential" phenomenon" for" MRGPRX2Emediated" MC"
activation."Ca2+"influx"is"mediated"by"different"calcium"channels"present"in"the"cell"
membrane."SyntaE66"and"GSKE7975A"are"both"Orai"inhibitors"that"have"shown"to"
attenuate" IgEEdependent"Ca2+" influx"and"mediators"release"[117]."However," the"
role"of"Orai"calcium"channels"in"LLE37"and"SP"induced"MRGPRX2EMC"activation"
remains" unknown."We" used"Orai" inhibitors" to" investigate" the" role" of"Orai" Ca2+"
channels"on"MRGPRX2Emediated"Ca2+"influx"and"degranulation."Initially"we"used"









Knockdown of STIM1 attenuates MRGPRX2 mediated Ca2+ influx and 








Orai1" channel" [122]."MCs" lacking"STIM1"demonstrated" substantial" inhibition" in"
FcεRIEmediated" Ca2+" influx" and" degranulation" [123]." Therefore," we" utilized"






D)" compared" to" control" shRNA" transduced" cells." Similarly," SPEmediated"
MRGPRX2"Ca2+" influx" and" degranulation"were" substantially" reduced" in" STIM1"
knockdown"LAD2"cells"(Fig."8"C"and"D)."
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Orai1 knockdown LAD2 cells demonstrated marked decrease in MRGPRX2 















development." A" unique" feature" of" rosacea" is" that" it" is" characterized" by"
dysregulation" of" the"host" defense"mechanisms"and"overexpression"of" the" host"
defense"antimicrobial"peptide"LLE37."Moreover,"NPs"such"as"SP"play"a"key"role"in"
rosacea" exacerbation" and" flareEup" [20]." LLE37" and" SP" are" known" ligands" that"
activate"MCs"through"a"cell"surface"receptor"known"as"MRGPRX2"[40,"41,"108]."
MRGPRX2" and" its" murine" ortholog" of" the" human" receptor" are" predominantly"










mouse"model" when"Onabotulineium" toxin" (BoNT)"was" used" as" an" inhibitor" for"
MCs." The" explanation" this" study" provided" was" that" BoNT" is" involved" in" the"
blockage"of"MC"degranulation"by"preventing"granules"fusion"and"release."Muto"et"
al." [108]"showed" that"MCEdeficient"mice" failed" to"demonstrate"erythema" in#vivo"
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when" injected"with" LLE37" intradermally." In" agreement" to" previous" studies" [108,"
124],"our" results"demonstrate" that"MCEdeficient"mice" failed" to"display"erythema"
presentation"as"compared"to" the"WT"group,"indicating" the"central"role"of"MC"in"
rosacea."This"was"correlated"with"the"histological"finding"which"indicated"absence"
of" infiltrated"cells" in" the"skin."Moreover,"our" IHC"and"IF"data"of" the"human"skin"





less" erythema" presentation" and" less" inflammatory" cell" infiltration" histologically"














generally" accepted" that" MC" activation" by" NPs" contributes" to" neurogenic"
inflammation," pain," and" itch" [20]."Proteases" released"by"MCs"directly" signal" to"
neurons"through"proteinaseEactivated"receptor"2"(PARE2)"to"stimulate"the"release"
of"SP,"which"mediates"inflammatory"edema""[23]."The"activation"of"CTMCs"through"
MRGPRX2/Mrgprb2" results" in" the" release" of" inflammatory" mediators" via"
degranulation"in#vitro"[23]."Our"study"confirmed"this"result"with"in#vitro#and"in#vivo#
experiments.#Utilizing"CTMCs"isolated"from"the"peritoneal"cavity"from"both"WT"and"
Mrgprb2E/E"mice," degranulation"with" SP"was" significantly" reduced" in"Mrgprb2E/EE
PMCs.#Similarly,"mRNA"expression"level"of"MMP+9"and"CXCl+2"were"significantly"
less"in"Mrgprb2E/E"mice"compared"to"the"WT"when"mice"were"injected"intradermally"
with" SP" indicating" that" they" are" MRGPRX2/Mrgprb2" dependent." Recently," in"
accordance" to" our" findings"Green" et" al." [127]" used" a" similar"Mrgprb2E/E"mouse"
model" and" demonstrated" less" inflammatory" cell" infiltration," protease" and"
chemokine"production"after"SP"was"injected"into"mice"hindpaws"compared"to"WT."
In" another" recent" study"Meixiong"et" al.[128]"showed" that"Mrgprb2E/E"mice"were"
protected" from"allergic"contact"dermatitisEassociated" itch"with" lower"CD45+"cells"
infiltration"compared"to"WT."Thus,"our"findings"as"well"as"those"of"other"studies"











induced" receptor" phosphorylation," desensitization," and" internalization" [67]."
Therefore,"absence"of"MRGPRX2"desensitization"result"in"continues"activation"of"
MCs" and" possibly" increase" the" expression" of" TRPV4." The" fact" that" TRPV4"
inhibitors"and"TRPV4"deficientEMCs"showed"only"partial"reduction"of"MRGPRX2"






















isolated" from" the"skin."We" therefore"proceeded"with"LAD2"cells" to"conduct" the"
remaining" experiments." Likewise," MRGPRX2" mediated" Ca2+" mobilization" and"
degranulation" assays" demonstrated" significant" reduction" with" Orai" inhibitors" in"
LAD2." Also," silencing" of" STIM1" and" Orai1" had" a" significant" effect" on" IgE"
independent"MRGPRX2"mediated"degranulation"and"Ca2+"influx"when"MCs"were"
stimulated" with" LLE37" and" SP." Moreover," qPCR" showed" slight" reduction" in"
transcript" level" of" Orai1" at" 24" hours" (data" not" shown)" when" LAD2" cells" were"
continually" stimulated" with" LLE37." Although" this" reduction" was" not" statistically"
significant,"but"it"suggests"that"changes"in"expression"between"TRPV4"and"Orai1"
is"to"possibly"fineEtune"the"Ca2+"influx"according"to"the"MC"needs."Taken"together,"
these" results" show" that" there" is" significant" therapeutics" potential" to" target"
STIM1/Orai1"for"the"treatment"of"rosacea."




rosacea."One"of" the"most" significant" findings" to" emerge" from" this" study" is" that"






























































































Fig. 2: Peritoneal mast cells isolated from Mrgprb2-/- mice exhibited partial 
reduction degranulation following LL-37 stimulation compared to WT peritoneal 
mast cells. 
(A)" Agarose"gel" electrophoresis" shows" success" in" generating"Mrgprb2E/E"
mice"using"CRISPR/Cas9"technology."(B)"PMCs"were"cytocentrifuged"and"stained"
with" Alcian" blue/Safranin" red." (C)" PMCs" were" stimulated" with" DNPEBSA" (100"
ng/ml)."(D)"PMCs"were"stimulated"with"48/80"(10"ng/ml),"LLE37"(10"µM)"and"SP"
(100"µM)"for"30"minutes,"and"βEhexosaminidase"release"was"measured."Statistical"

























Fig. 3: Mrgprb2-/- mice displayed significantly less erythema. 
(A)"WT,"Mrgprb2E/E," and"MC"deficient"mice" (Wsh/Wsh)" were" intradermally"
injected"with" filtered"PBS"(control)"or"LLE37"(320"µM)" in" the"dorsum"skin." (B)"A"
comparison" of" the" size" of" erythema"measured" (mm2)" 72" hours" after" the" initial"








































Fig. 4: Robust inflammatory cells infiltration in WT experimental mice compared to 
Mrgprb2-/- and MC-deficient mice. 
(A)"WT,"Mrgprb2E/E," and"Wsh/Wsh"were" intradermally" injected"with" filtered"
PBS"(control)"or"LLE37"(320"µM)"and"then"were"stained"via"hematoxylin/eosin."(B)"
The"mean"±"S.E.M"of"inflammatory"cells"infiltration"per"HPF"was"plotted."Statistical"










































Fig. 5: CXCL-2 and MMP9 are overexpressed in WT experimental group but 
reduced in Mrgprb2-/- and Wsh/Wsh following intradermal injection with LL37. 
Skin"was"excised"from"mice"intradermally"injected"with"LLE37"(320"µM),"and"
mRNA" transcripts" level" of" (A),"CXCL+2" and" (B),"MMP+9#was" determined" with"
























































Fig. 6: Mrgprb2 mediates SP induced MC CXCL-2 and MMP-9 release. 
Skin"was"excised"from"mice"intradermally"injected"with"SP"(100"µM),"and"


























































Fig. 7: Mast cells isolated from the skin of human subjects and LAD2 cells displayed 
a significant reduction in degranulation with Orai inhibitors. 
Human" skin" MCs" were" isolated," cytocentrifuged," and" stained" for" (A)"
Immunofluorescence" staining"with"DAPI" (Blue)," FC!R" (Green)," and"MRGPRX2"
(Red)." (B)" Degranulation" in" nonEtreated" (no" inhibitors)" and" preEtreated" (with"
inhibitors)"human"skin"MCs"with"Orai"inhibitors"(10"µM"of"SyntaE66"or"GSKE7975A)"





















































Fig. 8: Knockdown of STIM1 significantly reduced LL-37 and SP induced calcium 
mobilization and degranulation. 
LAD2" cells" were" transduced"with" scrambled" shRNA" control" lentivirus" or"
shRNA"lentivirus" targeted"against"STIM1."(A)," representative" immunoblot"of" the"
transduced"LAD2"is"shown.""Transduced"cells"were"stimulated"were"incubated"with"
FuraE2,"washed"and"resuspended"in"Ca2+"free"buffer,"and"stimulated"with"(B),"3"
µM" LLE37" or" (C)," 1" µM" SP" at" 100" seconds" and" Calcium" mobilization" was"
determined"in"the"absence"of"extracellular"calcium."At"400"seconds,"1"mM"of"Ca2+"
was" added" and" Ca2+" influx" was" determined." (D)," Control" shRNA," and" STIM1"
shRNA"transduced"cells"were"stimulated"with"3"µM"of"LLE37"and"0.5"µM"of"SP,"















































Fig.  9: Knockdown of Orai1 significantly reduced LL-37 and SP induced calcium 
mobilization and degranulation. 




















 Chapter 4: Naturally occurring Missense MRGPRX2 
variants display Loss of Function Phenotype for Mast Cell 
Degranulation in response to Substance P, Hemokinin-1, 
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Abstract!
Human" mast" cells" (MCs)" express" a" novel" G" proteinEcoupled" receptor"
(GPCR)," known" as" MasErelated" G" protein" coupled" receptor" X2" (MRGPRX2)."
Activation" of" this" GPCR" by" a" diverse" group" of" cationic" ligands" such" as"
neuropeptides"(NPs),"host"defense"peptides"(HDPs)"and"Food"and"Drug"Approved"
drugs" contributes" to" chronic" inflammatory" diseases" and" pseudoEallergic" drug"
reactions." For" most" GPCRs," the" extracellular" domains" and" their" associated"
transmembrane" domains" display" the" greatest" structural" diversity" and" are"
responsible" for" binding" different" ligands."The" goal" of" the" present" study"was" to"
determine" if" naturally" occurring" missense" variants" within" MRGPRX2’s"
extracellular/transmembrane" domains" contribute" to" gain" or" loss" of" function"
phenotype" for" MC" degranulation" in" response" to" NPs" (substance" Pk" SP" and"
hemokininE1,"HKE1),"an"HDP"(human"βEdefensinE3,"hBD3)"and"an"FDAEapproved"
cationic" drug" (bradykinin" B2" receptor" antagonist," icatibant)."We" have" identified"
eight"missense"variants"within"MRGPRX2’s"extracellular/transmembrane"domains"
from"publically"available"exomeEsequencing"databases."We"investigated"the"ability"
of" MRGPRX2" ligands" to" induce" degranulation" in" RBLE2H3" cells" individually"
expressing"these"naturally"occurring"MRGPRX2"missense"variants."Using"stable"
and" transient" transfections," we" found" that" all" variants" express" in" RBL" cells."
However," four" natural" MRGPRX2" variants," G165E" (rs141744602)," D184H"
(rs372988289)," W243R" (rs150365137)" and" H259Y" (rs140862085)" failed" to"
respond" to" any" of" the" ligands" tested." Thus," diverse" MRGPRX2" ligands" utilize"
common"sites"on"the"receptor"to"induce"MC"degranulation."These"findings"have"
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and" icatibant" contribute" to" the" pathogenesis" of" chronic" urticaria," asthma,"
periodontitis" and" pseudoEallergic" reactions."Modeling" and"mutagenesis" studies"
with"SP"and"various"opioid" ligands" led" to" the"suggestion" that"different"agonists"
interact"with"different"amino"acid"residues"in"MRGPRX2’s"predicted"ligandEbinding"
pocket"to"induce"MC"degranulation"[139,"140]."However,"the"sites"of"interaction"of"
HKE1," hBD3" and" icatibant" on"MRGPRX2" for"MC" degranulation" have" not" been"
determined."""
Recent" crystallography" data" obtained" for" a" number" of" GPCRs" and"
comparison"of"sequence"homology"have"provided"prediction"regarding"the"regions"
of"GPCRs" that"are" involved" in" ligand"binding"and"G"protein"coupling."The"7TM"
bundles"are"connected"by"three"extracellular"loops"(ECL1,"ECL2"and"ECL3)"and"






We" have" identified" eight" naturally" occurring" missense" variants" within"
MRGPRX2’s" extracellular" and" transmembrane" domains" from" three" publically"
available" databasesk" Exome" Sequencing" Project" (NHLBIEGOEESP)," 1000"
Genomes"project"and"Exome"Aggregation"Consortium" (ExAC)."The"goal"of" the"
present" study"was" to" determine" if" any" of" these" variants" display" gain" or" loss" of"
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function"phenotype"for"MC"degranulation" in"response"to"NPs"(substance"Pk"SP"








All" cell" culture" reagents" and" IndoE1" were" purchased" from" Invitrogen"
(Gaithersburg,"MD)." Substance" P," FluorescentElabeled" substance" P" (FAMESP),"
hBD3" and" icatibant" were" purchased" from" Anaspec" (Fremont," CA)." Human"
hemokininE1"was"purchased"from"Alpha"Diagnostic"(San"Antonio,"TX)."MRGPRX2"
plasmid" encoding" hemagglutinin" (HA)Etagged" human"MRGPRX2" in" pReceiverE
MO6"vector"was"obtained"from"GeneCopoeia"(Rockville,"MD)."Amaxa"transfection"
kit" (Kit" V)" was" purchased" from" Lonza" (Gaithersburg," MD)." PEEAnti" human"
MRGPRX2"was"obtained"from"Biolegend"(San"Diego,"CA)."QuikChange"II"SiteE








Site-directed mutagenesis  
Quick" II" change" siteEdirected" mutagenesis" kit! (Agilent)" was" used" to"








GTGGCAAGGAGACCGTGATCCCGGTCTTCE3’" V43I:" Forward:" 5’E
TTTCCTACCAGCCCGATCAGGGCAATGAAAAGGE3’Reverse:" 5’E
CCTTTTCATTGCCCTGATCGGGCTGGTAGGAAAE3’" F78L:" Forward:" 5’E
GGAAGCAGAGTAAGAGGAAGTCGGCCCCGE3’" Reverse:" 5’E
CGGGGCCGACTTCCTCTTACTCTGCTTCCE3’" G165E:" Forward:" 5’E
GCTGAGCATCTTGGAAGAGAAGTTCTGTGGCTTCTE3’" Reverse:" 5’E










Transfection of RBL cells and Flow cytometry 
Cells" (1." 5" x106)" were" transfected" with" plasmids" (1.5" µg)" encoding"
MRGPRX2" or" its"missense" variants" using" the" Amaxa"Nucleofector" device" and"
Amaxa"kit"V"according"to"the"manufacturer's"protocol."For"stable"transfection,"cells"
were"cultured"in"the"presence"of"GE418"(1"mg/ml)"and"used"within"one"month"of"
transfection" [41]." For" transient" transfection," cells"were" used"within"16E20"hours"
after" transfection." To" detect" MRGPRX2" expression," cells" (0.5" x" 106)" were"
incubated"with"PEEconjugated"antiEMRGPRX2"antibody,"washed"in"FACS"buffer,"
fixed"and"analyzed"on"a"BD"LSR"II"flow"cytometer."For"FAMESP"binding"RBLE2H3"















HEPES" buffer" containing" 0.1%" bovine" serum" albumin" (BSA)" and" exposed" to"
ligands"for"30"minutes."Cells"without"treatment"were"designated"as"controls."For"







Identification of D184H and G165E as loss of function MRGPRX2 variants for 
SP, hemokinin-1, hBD3 and Icatibant in stably transfected RBL-2H3 cells 
To" identify" naturally" occurring"missense" variants" in" the" extracellular" and"








annotationEdependent"depletion"(CADD)" is"an" in"silico" tool"used" for"scoring" the"
deleteriousness"of"single"nucleotide"variants"as"well"as"insertion/deletion"variants"
in"the"human"genome"[142]."A"CADD"score"of">10"indicates"that"a"variant"may"be"
deleterious."As"shown" in"Fig." "1B,"all"eight"MRGPRX2"variants" targeted" for" the"
present"study"have"CADD"scores"of"<10."Thus,"the"combined"in"silico"analyses"
suggest" that" although" some" of" the" MRGPRX2" variants" may" be" damaging"







not" endogenously" express" the" receptor" [92," 93]." To" determine" if" any" of" the"
MRGPRX2" variants" shown" in" Fig." " 1" display" gain" or" loss" of" function" for" MC"
activation," we" first" generated" stable" transfectants" in" RBL" cells." The" stable"
transfection"procedure"involves"cDNA"nucleofection"followed"by"culturing"cells"in"
the" presence" of" selection"marker" G418."We" were" quite" surprised" to" find" cells"




H259Y" transfectants."We"used"Triton"X" to" lyse" the"cells"and"measured" total"$E
hexosaminidase"content"as"an"assay"to"quantitate"cell"number."As"shown"in"Fig.""
2A,"unlike"the"situation"with"cells"expressing"the"WT"receptor,"we"could"not"detect"




probably" the"most"well" characterized" [40,"43,"45,"130,"132,"140]."We" therefore"
tested"the"effects"of"SP"on"Ca2+"mobilization"and"degranulation"in"cells"expressing"
these" variants." We" found" that" the" variants" L31V," V43I" and" F78L" responded"












F78L," G165E" and" D184H)" on" degranulation" in" response" to" HKE1," hBD3" and"
icatibant."As"shown"in"Fig.""3,"AEC,"cells"expressing"L31V,"V43I"or"F78L"variant"






activation" in" missense" variants" correlates" with" correspondingly" reduced" ligand"
binding"to"MRGPRX2."Of"the"agonists"used"in"this"study,"only"SP"is"available"as"a"




or" Icatibant." For" these" studies," we" used" RBL" cells" stably" overexpressing"
MRGPRX2"(RBLEMRGPRX2)."We"confirmed"cell"surface"MRGPRX2"expression"
by" flow" cytometry" using"PEEconjugated"antiEMRGPRX2"antibody" (Fig." " 4A)." To"
validate"the"functional"activity"of"FAMESP"for"MRGPRX2,"we"compared"its"ability"
to"induce"degranulation"in"untransfected"RBL"and"RBLEMRGPRX2"cells."As"shown"





interaction"with" the"plasma"membrane"even" in" the"absence"of"MRGPRX2," thus"
making"it"difficult"to"perform"the"proposed"binding"studies.""
 
Identification of W243R and H259Y as loss of function MRGPRX2 variants 
for SP, HK-1, hBD3 and Icatibant in transiently transfected RBL cells 
The" low" PolyPhenE2" score" for" the"MRGPRX2" variant" H259Y" (Fig." " 1B)"
indicates" that" this" mutation" is" benign." Thus," our" inability" to" generate" a" stable"
transfectant" expressing" this" variant" in" RBL" cells" was" surprising."We" therefore,"
generated" transient" transfectant" in" RBL" cells" expressing" H259Y." We" also"
performed" similar" studies" with" two" other" variants" with" high" PolyPhen2" score"













cationic" ligands" [40," 43," 92," 93]." Emerging" evidence" suggests" that"MRGPRX2"






eight" naturally" occurring" missense" MRGPRX2" variants" and" identified" rare"
mutations"that"display"loss"of"function"phenotype"for"MC"degranulation"in"response"




as" the"negatively"charged" residues" that"make" ionic"contact"with"cationic"opioid"






in" loss" of" ligandEreceptor" interaction." However," MRGPRX2" activation" by" a"




and" endogenous" opioid" peptide" metabolites." Using" publically" available" web"
portals,"Reddy"et"al.," [139]"also"predicted" that"SPEbinding"pocket" in"MRGPRX2"
consists"of"a"number"of"structurally"conserved"hydrophilic"residues"along"with"a"
buried"glutamic"acid"residue"(Glu164,"E164)."Accordingly,"replacement"of"Glu164"with"
a" positively" charged" Arg" (E164R)" results" in" loss" MRGPRX2" activation" by" SP."
However,"this"mutant"respond"normally"to"the"host"defense"peptide,"LLE37"[139]."
These" findings" suggest" that" different" ligands" interact" with" different" amino" acid"






G165E" (MAFk" <0.01%)" that" warrant" discussion." First," it" is" present" within" the"
predicted"binding"pocket"for"opioids"and"SP,"as"determined"from"modeling"studies"
[139," 140]." Second," although" we" were" unsuccessful" in" demonstrating" specific"
binding"of" FAMESP" to"RBL" cells" stably" overexpressing"MRGPRX2"due" to"high"
background"binding," it" is" likely" that" this"mutation" interferes"with"SP’s"binding" to"
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MRGPRX2."This" contention"was" supported"by" the" finding" that" cells" expressing"
G165E" variant" did" not" respond" to"SP" for"Ca2+"mobilization" despite" normal" cell"
surface" expression." Third," and"most" importantly," none"of" the" other"MRGPRX2"
ligands" tested" caused" degranulation" in" cells" expressing" this" variant." It" is"




in" the"variant"G165E" interferes"with" the" integrity"of" the"binding"pocket"and"thus"
preventing"MC"activation"by"SP"and"all"other"cationic"ligands"used"in"this"study.""
Studies"by"Reddy"et"al.,"[139]"did"not"consider"Asp184"as"a"possible"site"for"
SP" interaction" with" MRGPRX2" despite" the" fact" this" amino" acid" is" critical" for"
receptor"activation"of"by"all"opioid"ligands"tested,"including"dynorphin"A"[140]."It"is"
interesting" to" note" that" the" naturally" occurring" D184H" variant" results" in" the"









7th" TM" domains" outside" MRGPRX2’s" predicted" ligand" binding" pocket" also"
rendered"the"receptor"unresponsive"to"all"ligands"tested."The"mechanism"by"which"
these"mutations"lead"to"loss"of"degranulation"is"unknown."Interestingly,"we"found"
that"while"cells"expressing" these"variants"do"not"survive" the"stable" transfection"
procedure" they" express" normally" in" transiently" transfected" cells." It" is" therefore"
possible"that"replacement"of"the"bulky"Trp"with"a"positively"charged"Arg"in"variant"
W243R" and" His" with" Tyr" in" variant" H269Y" influences" both" the" receptor’s"
expression"status"and"its"ability"to"interact"with"diverse"ligands."In"future"studies,"it"
will" be" interesting" to" determine" the" MC" status" of" individuals" harboring" these"
mutations"and"their"responsiveness"to"MGRPRX2"ligands.""
In" summary," we" have" shown" that" naturally" occurring" rare" MRGPRX2"
variants" with" single" amino" acid" substitution" in" the" receptor’s" predicted" ligand"
binding"pocket"(G165E"and"D184H)"renders"it"unresponsive"to"SP,"HKE1,"hBD3"
and" icatibant" for" MC" degranulation." Although" the" naturally" occurring" variants"
W243R"and"H259Y" in" the" receptor’s" 6th" and"7th" TM"domain" also" rendered" the"
receptor"unresponsive"to"all"ligands"tested"for"degranulation,"the"mechanisms"of"
their" actions" are" unknown" and" remain" to" be" determined." An" important" clinical"
implication"of"the"present"study"is"that"individuals"harboring"any"of"the"missense"
MRGPRX2"mutation"(G165E,"D184H,"W243R"or"H259Y)"may"be"protected"from"
MCEmediated" drugEinduced" pseudoEallergy" and" chronic" inflammatory" diseases"
such"as"itch,"chronic"urticaria,"asthma"and"periodontitis."A"goal"of"our"future"studies"















































Fig.  1: Naturally occurrence MRGPRX2 variants identified from the NHLBI GO 















































Fig.  2: Effects of naturally occurring MRGPRX2 mutations (L31I, V43I, F78L, 
G165E and D184H) on cell surface expression, SP-induced Ca2+ mobilization and 
degranulation in stably transfected RBL cells.  
(A),!Cells" were" transfected" with" cDNA" encoding" wildEtype" (WT)," N16H,"
W243R,"or"H253Y"variant,"transferred"to"24"well"plate"and"G418"was"added"to"the"
culture"medium"16"hours"after"transfection."After"5"days,!nonEadherent"cells"were"


















Fig.  3: Effects of naturally occurring MRGPRX2 mutations (L31I, V43I, F78L, 
G165E and D184H) on HK-1, hBD3 and icatibant-induced degranulation in stably 
transfected RBL cells. 





















Fig.  4: FAM-SP-induced degranulation and binding in RBL cells overexpressing 
MRGPRX2.  
(A),!RBL"cells" stably" overexpressing"MRGPRX2" (RBLEMRGPRX2)"were"















Fig.  5: Effects of naturally occurring MRGPRX2 mutations (N16H, W243R and 
H259Y) on cell surface expression, Ca2+ mobilization and SP-induced degranulation 
in transiently transfected RBL cells. 
!(A),!Flow"cytometry"was"performed"using!PEEantiEMRGPRX2"antibody"to"
determine" cell" surface" expression" of" wildEtype" (WT)" and" variants" in" transiently"
transfected" in" RBL" cells." Representative" histograms" for" WT/Variant" (black#





























Fig.  6: Effects of MRGPRX2 mutations (N16H, W243R and H259Y) on 






















Conclusion and Future Directions 
MCs"are"pleiotropic"cells" that"can"be"activated" through"various"receptors"
when" they" are" exposed" to" the" corresponding" ligands." Activated" MCs" release"
several" mediators" which" can" have" proinflammatory," antiEinflammatory," or"
immunoregulatory"functions."In"this"thesis"I"discussed"the"possible"role"of"GPCR"
MRGPRX2/Mrgprb2"that"known"to"be"expressed"predominantly"in"MCs"among"all"




protection" against" pathogens" was" discussed" in" the" second" chapter." We"
demonstrated" the" ability" of" the" novel" compounds" named" small" molecule" Host"
Defense" Peptidomimetics" (smHDPMs)" in" inducing" MCs" degranulation" via" this"
receptor" and" its" possible" significant" impact" when" treating" multidrug" resistant"
microbes"not"only"by"its"direct"antimicrobial"activity"but"by"harnessing"MCs"activity"
as"well.""
The"other" side" of" the" coin" is" the" negative" role" of"MRGPRX2/Mrgprb2" in"
mediating"MCs"activation"when"the"innate"host"defense"is"dysregulated."This"was"
discussed"in"the"third"chapter"in"the"contest"of"rosacea."In"addition"to"C57BL/6"and"
MCEdeficient" (Wsh/Wsh)"mouse"models,"we"used"a"Mrgprb2" E/E"mouse"model" to"
delineate" the"MC" and" receptor" role" in" rosacea" pathogenesis."We" showed" that"
MRGPRX2/Mrgprb2" is"a"major"effector" in"mediating"MC"activation"and" immune"
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cells" recruitments" in" rosacea" in#vitro"and" in#vivo." It" is" important" to"consider" the"
possible"differences"between"the"human"and"mouse"receptor"that"we"discussed"
earlier" in" chapter" one" in" regard" to" the" differences" in" the" ligand" concentration"
required"to"stimulate"MRGPRX2"(human)"or"Mrgprb2"(mouse)"[40]."This"renders"
the"mouse"receptor"unsuitable"to"screen"drugs"to"be"used"in"humans.""
Growing" evidence" indicating" TRPV4" is" significantly" involved" in" rosacea"
development"[113,"115]."However,"TRPV4"inhibitor"and"TRPV4Eknockdown"CD34+"
derived"MCs" only" resulted" to" in" partial" reduction" in" MRGPRX2"mediated"MCs"







line" to" overcome" this" limitation" and" to" conduct" more" experiments" using"
pharmacological"and"genetic"approaches."Thus,"we"believe"chapter"three"adds"to"
the" growing" body" of" research" that" indicates" the" pivotal" role" of" MCs" and" Ca2+"
channels"in"rosacea."Future"researches"can"focus"on"delineating"the"role"of"other"
members"of"the"Orai"Ca2+"channels,"Orai2"and"Orai3"and"to"possibly"enhance"the"




MRGPRX2" itself." MRGPRX2" consists" of" amino" acids" which" form" seven"
transmembrane"(TM)"bundles"that"are"connected"by"three"extracellular"loops"and"
three" intracellular" loops." We" selected" eight" missense" mutants" that" located" in"
extracellular" (EC)" and" ECETM" regions" according" to" crystallography" data" and"
comparison"of"sequence"homology."These"regions"are"known"to"be" involved" in"
ligand"binding"[150]."We"have"shown"that"the"replacement"of"neutral"or"negatively"
charged" amino" acid" residues" in" the" ligand" binding" pocket" of" MRGPRX2" with"
positively"charged"residues"in"the"naturally"occurring"MRGPRX2"variants"(G194E"





their" actions" are" unknown" and" remain" to" be" determined." Nevertheless," an"
important"clinical"implication"for"this"chapter"is"that"individuals"harboring"any"of"the"
single"loss"of"function"missense"mutation"(G165E,"D184H,"W243R"and,"H259Y)"
may" be" protected" from" MRGPRX2Emediated" pseudoEallergy" and" chronic"
inflammatory" diseases." The" presence" of" these" mutations" may" thus" serve" as"
biomarkers"to"predict"individuals"who"may"be"resistant"to"developing"injection"site"
reactions" to" commonly" used" drugs" and" MCEmediated" chronic" inflammatory"
diseases.""
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